期刊文献+

120例三阴乳腺癌患者的临床特征及预后因素分析 被引量:1

Clinical characteristics and prognostic factors analysis of 120 patients withtriple-negative breast cancer
下载PDF
导出
摘要 目的 探讨三阴乳腺癌患者临床特征及预后因素.方法 本文选择我院2015 年1 月至2015 年12 月收治的三阴乳腺癌患者120 例为观察组,同时收集同期非三阴乳腺癌患者120 例为对照组;分析两组患者临床病理特征,总结出患者临床病理特征及其预后因素.结果 观察组患者年龄低于对照组、患者大肿块发生率及脉管转移率高于对照组,差异有统计学意义(P 〈 0. 05).结论 三阴乳腺癌患者年龄小,且极具侵袭性,预后因素均是患者年龄与淋巴结转移率,治疗中要高度重视其预后因素. Objective To investigate the clinical characteristics and prognostic factors of triple-negative breast cancer.Methods 120 cases of triple-negative breast cancer patients treated in our hospital from January 2015 to December 2015 wereselected as the observation group, while 120 cases of non-triple-negative breast cancer were collected as the control group; andthen to analyze the clinicopathological features of these two groups; to sum up the clinical and pathological characteristics ofpatients and their prognostic factors. Results The age of the patients of the observation group was lower than that of the controlgroup; the incidence of large lumps and the rate of vessel metastasis in observation group were higher than that in the controlgroup; the difference was statistically significant (P 〈0.05). Conclusion The triple-negative breast cancer attacks the youngpatients and is very aggressive. The prognostic factors are patient’s age and the rate of lymph node metastasis, which are ofgreat importance in the treatment.
作者 宋小颖
出处 《临床研究》 2017年第8期19-20,共2页 Clinical Research
关键词 三阴乳腺癌 临床病理特征 预后因素 triple-negative breast cancer, clinicopathological features, prognostic factors
  • 相关文献

参考文献8

二级参考文献111

  • 1莫军,杨丽珍,李景,邢自良.化学发光法检测妇女血清睾酮及其临床应用[J].现代检验医学杂志,2007,22(2):105-106. 被引量:9
  • 2Bonasio R, von Andrian UH. Generation, migration and function of circulating dendritic cells [J]. Curr Opin Immunol, 2006, 18(4): 503-11. 被引量:1
  • 3Venkitaraman R. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features[J]. Expert Rev Anticancer Ther, 2010, 10(2): 199-207. 被引量:1
  • 4Scott-Taylor TH, Pettengell R, Clarke I, et al. Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines[J]. Biochim Biophys Acta, 2000, 1500(3): 265-79. 被引量:1
  • 5Kichler-Lakomy C, Budinsky AC, Wolfram R, et al. Deficiences in phenotype expression and fimction of dentritic cells from patients with early breast cancer[J]. Eur J Med Res, 2006, 11(1): 7-12. 被引量:1
  • 6Iwamoto M, Shinohara H, Miyamoto A, et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas[J]. Int J Cancer, 2003, 104(1): 92-7. 被引量:1
  • 7Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance [J]. Nat Rev Cancer, 2005, 5(4): 263-74. 被引量:1
  • 8Koido S, Nikrui N, Ohana M, et al. Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use[J]. Gynecol Oncol, 2005, 99(2): 462-71. 被引量:1
  • 9Xu F, Ye Y J, Liu W, et al. Dendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID mice[J]. Scand J Gastroenterol, 2010, 45(6): 707-13. 被引量:1
  • 10Homma S, Kikuchi T, Ishiji N, et al. Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12 [J]. Eur J Clin Invest, 2005, 35(4): 279-86. 被引量:1

共引文献65

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部